Centaurus Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
11,912
+38
+0.3% +$4.45K 0.06% 311
2026
Q1
$1.43M Sell
11,874
-19,825
-63% -$2.29M 0.07% 262
2025
Q4
$3.34M Buy
31,699
+6,741
+27% +$633K 0.15% 140
2025
Q3
$2.1M Buy
24,958
+1,371
+6% +$113K 0.1% 196
2025
Q2
$1.87M Sell
23,587
-119
-0.5% -$9.46K 0.11% 196
2025
Q1
$2.13M Buy
23,706
+12,800
+117% +$1.2M 0.13% 160
2024
Q4
$1.08M Sell
10,906
-1,743
-14% -$180K 0.07% 262
2024
Q3
$1.44M Sell
12,649
-229
-2% -$27.2K 0.09% 204
2024
Q2
$1.59M Buy
12,878
+178
+1% +$22.9K 0.11% 176
2024
Q1
$1.68M Sell
12,700
-231
-2% -$28.5K 0.12% 170
2023
Q4
$1.41M Sell
12,931
-417
-3% -$43.3K 0.11% 183
2023
Q3
$1.37M Sell
13,348
-1,156
-8% -$125K 0.12% 176
2023
Q2
$1.67M Sell
14,504
-5,510
-28% -$626K 0.15% 159
2023
Q1
$2.13M Buy
20,014
+2,092
+12% +$226K 0.17% 146
2022
Q4
$1.99M Sell
17,922
-106
-0.6% -$10.8K 0.19% 136
2022
Q3
$1.55M Buy
18,028
+296
+2% +$26.4K 0.15% 163
2022
Q2
$1.62M Buy
17,732
+2,229
+14% +$198K 0.16% 163
2022
Q1
$1.27M Buy
15,503
+680
+5% +$53.6K 0.1% 240
2021
Q4
$1.14M Buy
14,823
+688
+5% +$54.8K 0.09% 252
2021
Q3
$1.06M Buy
14,135
+1,222
+9% +$92.9K 0.09% 260
2021
Q2
$1M Buy
12,913
+510
+4% +$37.9K 0.08% 275
2021
Q1
$912K Sell
12,403
-465
-4% -$34.3K 0.09% 251
2020
Q4
$1M Sell
12,868
-1,001
-7% -$76.6K 0.11% 234
2020
Q3
$1.1M Buy
13,869
+1,442
+12% +$113K 0.15% 156
2020
Q2
$917K Sell
12,427
-89
-0.7% -$6.7K 0.14% 180
2020
Q1
$919K Buy
12,516
+6,927
+124% +$544K 0.18% 140
2019
Q4
$485K Buy
+5,589
New +$459K 0.07% 312
2019
Q3
Sell
-2,400
Closed -$192K 533
2019
Q2
$192K Buy
2,400
+43
+2% +$3.29K 0.03% 434
2019
Q1
$187K Buy
2,357
+261
+12% +$19.5K 0.03% 418
2018
Q4
$154K Hold
2,096
0.03% 384
2018
Q3
$145K Sell
2,096
-10,304
-83% -$656K 0.03% 443
2018
Q2
$718K Buy
+12,400
New +$700K 0.1% 218

Other funds holding MRK

Centaurus Financial's MRK Position: Q2 2026 in Review

Centaurus Financial increased its Merck (MRK) stake by 0.32% in Q2 2026, buying an estimated $4.45K and bringing the position to 11,912 shares worth $1.53M. The position accounts for 0.06% of the portfolio, ranked #311.

Centaurus Financial first reported a position in MRK in Q2 2018 and has held it in 32 quarters since. The position peaked at $3.34M in Q4 2025. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Centaurus Financial held 11,912 shares of Merck worth $1.53M as of Q2 2026.
  • Centaurus Financial bought 38 Merck shares in Q2 2026, an estimated $4.45K.
  • Merck made up 0.06% of Centaurus Financial's portfolio in Q2 2026, its #311 holding.
  • Centaurus Financial first reported a position in Merck in Q2 2018 and has held it in 32 quarters since.
  • Centaurus Financial's Merck position peaked at $3.34M in Q4 2025.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.